A prospective open-label study of sirolimus for the treatment of anti-Hu associated paraneoplastic neurological syndromes

BACKGROUND: Several lines of evidence suggest a T cell–mediated immune response in paraneoplastic neurological syndromes with anti-Hu antibodies (Hu-PNS). In order to investigate whether suppression of T cell–mediated immune responses in Hu-PNS patients improved their neurological outcome, we perfor...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: de Jongste, Adriaan H., van Gelder, Teun, Bromberg, Jacoline E., de Graaf, Marieke T., Gratama, Jan W., Schreurs, Marco W., Hooijkaas, Herbert, Sillevis Smitt, Peter A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2015
Aiheet:
Clinical Investigations
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4483045/
https://ncbi.nlm.nih.gov/pubmed/24994790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou126
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia